Tier 3 · Filer Universe

Gain Therapeutics, Inc.

GANX · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$2.01
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001819411
Liquidity rank
#4445
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenueNot publishedNot publishedNo matching frame
Annual diluted EPS-0.612025-12-310001104659-26-035188
Quarterly revenueNot publishedNot publishedNo matching frame
Quarterly diluted EPS-0.112026-06-300001104659-26-094048

SEC EDGAR Frames batch generated 2026-08-23T22:53:06.946Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames